Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Authors
Keywords
-
Journal
BLOOD
Volume 121, Issue 15, Pages 2975-2987
Publisher
American Society of Hematology
Online
2013-01-16
DOI
10.1182/blood-2012-08-448548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function
- (2012) D. W. McMillin et al. BLOOD
- Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth
- (2012) Matthew R. Porembka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
- (2012) Athanasios Kotsakis et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Toward integrative cancer immunotherapy: targeting the tumor microenvironment
- (2012) Leisha A Emens et al. Journal of Translational Medicine
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- The three main stumbling blocks for anticancer T cells
- (2012) Lukas Baitsch et al. TRENDS IN IMMUNOLOGY
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
- (2011) A. M. Lesokhin et al. CANCER RESEARCH
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer
- (2011) Güllü Görgün et al. Immunotherapy
- Novel therapies in MM: from the aspect of preclinical studies
- (2011) Teru Hideshima et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
- (2011) Melissa G Lechner et al. Journal of Translational Medicine
- Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
- (2010) G. Gorgun et al. BLOOD
- Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
- (2010) R. H. Prabhala et al. BLOOD
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-Derived Suppressor Cells in Human Cancer
- (2010) Srinivas Nagaraj et al. CANCER JOURNAL
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
- (2010) M. K. Brimnes et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
- (2010) Thomas Condamine et al. TRENDS IN IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer
- (2009) Chien-Ying Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immunosuppressive CD14+HLA-DRlow/−monocytes in prostate cancer
- (2009) Stanimir Vuk-Pavlović et al. PROSTATE
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-derived suppressor cell role in tumor-related inflammation
- (2008) Luigi Dolcetti et al. CANCER LETTERS
- Targeting the Stroma by T Cells to Limit Tumor Growth
- (2008) B. Zhang CANCER RESEARCH
- Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
- (2008) H. van Cruijsen et al. CLINICAL CANCER RESEARCH
- Reversal of Myeloid Cell-Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
- (2008) S. Kusmartsev et al. CLINICAL CANCER RESEARCH
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance
- (2008) Paola Allavena et al. IMMUNOLOGICAL REVIEWS
- Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating Factor
- (2008) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started